{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:39:51Z","timestamp":1792517991798,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373034"],"award-info":[{"award-number":["82373034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503422"],"award-info":[{"award-number":["82503422"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203716"],"award-info":[{"award-number":["82203716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX23_3617"],"award-info":[{"award-number":["KYCX23_3617"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.canlet.2026.218568","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:24:15Z","timestamp":1778023455000},"page":"218568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CircSPECC1 attenuates sensitivity to PD-1 blockade through impaired antigen presentation in hepatocellular carcinoma"],"prefix":"10.1016","volume":"652","author":[{"given":"Rui","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songsong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8032-7959","authenticated-orcid":false,"given":"Dousheng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218568_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218568_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218568_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000535338","article-title":"A phase 3 study of pembrolizumab versus placebo for previously treated patients from Asia with hepatocellular carcinoma: health-related quality of life analysis from KEYNOTE-394","volume":"13","author":"Qin","year":"2024","journal-title":"Liver Cancer"},{"key":"10.1016\/j.canlet.2026.218568_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S1470-2045(21)00252-7","article-title":"Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study","volume":"22","author":"Ren","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218568_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218568_bib6","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218568_bib7","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218568_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218568_bib9","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","article-title":"The hallmarks of cancer immune evasion","volume":"42","author":"Galassi","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218568_bib10","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nbt.3344","article-title":"Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes","volume":"33","author":"Shukla","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2026.218568_bib11","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1016\/j.cell.2023.07.016","article-title":"A membrane-associated MHC-I inhibitory axis for cancer immune evasion","volume":"186","author":"Chen","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218568_bib12","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1158\/2159-8290.CD-17-0593","article-title":"Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer","volume":"7","author":"Gettinger","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218568_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1074-7613(02)00263-7","article-title":"Disulfide bond isomerization and the assembly of MHC class I-peptide complexes","volume":"16","author":"Dick","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218568_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41580-023-00633-8","article-title":"Mechanisms of substrate processing during ER-associated protein degradation","volume":"24","author":"Christianson","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218568_bib15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218568_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.celrep.2016.03.058","article-title":"The biogenesis of nascent circular RNAs","volume":"15","author":"Zhang","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218568_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41576-024-00806-x","article-title":"The therapeutic potential of circular RNAs","volume":"26","author":"O'Leary","year":"2025","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2026.218568_bib18","first-page":"171","volume":"23","author":"Zhang","year":"2024"},{"key":"10.1016\/j.canlet.2026.218568_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003376","article-title":"circFAT1 promotes cancer stemness and immune evasion by promoting STAT3 activation","volume":"8","author":"Jia","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.canlet.2026.218568_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12943-024-02192-8","article-title":"Circular RNA circPHLPP2 promotes tumor growth and anti-PD-1 resistance through binding ILF3 to regulate IL36\u03b3 transcription in colorectal cancer","volume":"23","author":"Hu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218568_bib21","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.1038\/s41467-024-52981-4","article-title":"Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma","volume":"15","author":"Ge","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218568_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph1430s66","article-title":"The DEN and CCl4 -Induced mouse model of fibrosis and inflammation-associated hepatocellular carcinoma","volume":"66","author":"Uehara","year":"2014","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218568_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2022.02.019","article-title":"PKC\u03b1\/ZFP64\/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma","volume":"77","author":"Wei","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218568_bib24","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","article-title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","volume":"18","author":"Seymour","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218568_bib25","doi-asserted-by":"crossref","first-page":"D52","DOI":"10.1093\/nar\/gkad770","article-title":"circAtlas 3.0: a gateway to 3 million curated vertebrate circular RNAs based on a standardized nomenclature scheme","volume":"52","author":"Wu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218568_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","article-title":"RNA N(6)-methyladenosine modification in cancers: current status and perspectives","volume":"28","author":"Deng","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218568_bib27","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.7150\/ijbs.62767","article-title":"The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma","volume":"17","author":"Qin","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2026.218568_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218568_bib29","first-page":"14","article-title":"Endoplasmic reticulum-associated protein degradation","author":"Krshnan","year":"2022","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.canlet.2026.218568_bib30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tibs.2018.06.005","article-title":"Quality control in the endoplasmic reticulum: crosstalk between ERAD and UPR pathways","volume":"43","author":"Hwang","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2026.218568_bib31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","volume":"19","author":"Kristensen","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218568_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218568_bib33","article-title":"LNMAC promotes cervical squamous cell carcinoma lymphatic metastasis via epigenetic regulation of FGF2-Induced lymphangiogenesis","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.canlet.2026.218568_bib34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","article-title":"Circular RNA in cancer","volume":"24","author":"Conn","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218568_bib35","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrm954","article-title":"Formation and transfer of disulphide bonds in living cells","volume":"3","author":"Sevier","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218568_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030737","article-title":"Recognition dynamics of cancer mutations on the ERp57-Tapasin interface","volume":"12","author":"Padariya","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218568_bib37","doi-asserted-by":"crossref","first-page":"17587","DOI":"10.1074\/jbc.M702212200","article-title":"Major histocompatibility complex class I-ERp57-tapasin interactions within the peptide-loading complex","volume":"282","author":"Santos","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218568_bib38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coi.2021.02.004","article-title":"MHC I assembly and peptide editing - chaperones, clients, and molecular plasticity in immunity","volume":"70","author":"Thomas","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.canlet.2026.218568_bib39","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1038\/sj.emboj.7600814","article-title":"Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex","volume":"24","author":"Peaper","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2026.218568_bib40","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ni1485","article-title":"Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer","volume":"8","author":"Wearsch","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218568_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(25)01042-6","article-title":"The lancet commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment","author":"Chan","year":"2025","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.canlet.2026.218568_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s11658-024-00644-z","article-title":"A novel protein SPECC1-415aa encoded by N6-methyladenosine modified circSPECC1 regulates the sensitivity of glioblastoma to TMZ","volume":"29","author":"Wei","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.canlet.2026.218568_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111671","article-title":"m(6)A modification of circSPECC1 suppresses RPE oxidative damage and maintains retinal homeostasis","volume":"41","author":"Chen","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218568_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/vco.12475","article-title":"Cancer-testis antigens in canine histiocytic sarcoma and other malignancies","volume":"17","author":"Nemec","year":"2019","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.canlet.2026.218568_bib45","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1080\/15548627.2024.2325304","article-title":"Lopinavir enhances anoikis by remodeling autophagy in a circRNA-dependent manner","volume":"20","author":"Wu","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218568_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103449","article-title":"Macrophage metabolic reprogramming ameliorates diabetes-induced microvascular dysfunction","volume":"79","author":"Zhang","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218568_bib47","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1016\/j.clbc.2023.11.009","article-title":"Interference of the circular RNA sperm antigen with calponin homology and coiled-coil domains 1 suppresses growth and promotes apoptosis of breast cancer cells partially through targeting miR-1236-3p\/Chromobox 8 pathway","volume":"24","author":"Zhang","year":"2024","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.canlet.2026.218568_bib48","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.21037\/jtd-2024-2144","article-title":"Circular RNA SPECC1 promoted tumorigenesis and osimertinib resistance in lung adenocarcinoma via a circular RNA-microRNA network","volume":"16","author":"Hao","year":"2024","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.canlet.2026.218568_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6956038","article-title":"circSPECC1 promotes proliferation and migration of LNCaP prostate cancer cells by affecting their epithelial-mesenchymal transition","volume":"2023","author":"Xie","year":"2023","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.canlet.2026.218568_bib50","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/2159-8290.CD-23-0519","article-title":"NKG2A is a therapeutic vulnerability in immunotherapy resistant MHC-I heterogeneous triple-negative breast cancer","volume":"14","author":"Taylor","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218568_bib51","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s43018-023-00600-4","article-title":"CD8(+) T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis","volume":"4","author":"Lerner","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218568_bib52","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41590-022-01291-2","article-title":"Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy","volume":"23","author":"Grisaru-Tal","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218568_bib53","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218568_bib54","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.immuni.2023.09.004","article-title":"Cancer cell-intrinsic mechanisms driving acquired immune tolerance","volume":"56","author":"Ghorani","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218568_bib55","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Sung","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218568_bib56","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/hep.26540","article-title":"Identification of driver genes in hepatocellular carcinoma by exome sequencing","volume":"58","author":"Cleary","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218568_bib57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3350\/cmh.2015.21.3.220","article-title":"The mutational landscape of hepatocellular carcinoma","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218568_bib58","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jamasurg.2025.0242","article-title":"Molecular testing and targeted therapies in hepatobiliary cancers: a review","volume":"160","author":"Tsilimigras","year":"2025","journal-title":"JAMA Surg."},{"key":"10.1016\/j.canlet.2026.218568_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molcel.2015.06.010","article-title":"Pathogenic hijacking of ER-Associated degradation: is ERAD flexible?","volume":"59","author":"Morito","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218568_bib60","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1126\/science.aao6001","article-title":"Structure of the TAPBPR-MHC I complex defines the mechanism of peptide loading and editing","volume":"358","author":"Thomas","year":"2017","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.canlet.2026.218568_bib61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218568_bib62","doi-asserted-by":"crossref","first-page":"20597","DOI":"10.1073\/pnas.2004445117","article-title":"Atomistic structure and dynamics of the human MHC-I peptide-loading complex","volume":"117","author":"Fisette","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.canlet.2026.218568_bib63","article-title":"Defects in antigen processing and presentation: mechanisms, immune evasion and implications for cancer vaccine development","author":"Huber","year":"2025","journal-title":"Nat. Rev. Immunol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:02:17Z","timestamp":1792515737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526003319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":63,"alternative-id":["S0304383526003319"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218568","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CircSPECC1 attenuates sensitivity to PD-1 blockade through impaired antigen presentation in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218568"}}